Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dbv Technologies ADR (NQ: DBVT )

1.350 -0.030 (-2.17%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 137,989
Open 1.380
Bid (Size) 1.300 (20)
Ask (Size) 1.430 (1)
Prev. Close 1.380
Today's Range 1.330 - 1.390
52wk Range 1.080 - 3.430
Shares Outstanding 55,096,537
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
From DBV Technologies S.A.
Via Globe NewsWire
Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2022
From DBV Technologies S.A.
Via Globe NewsWire

Performance

YTD
-10.00%
-10.00%
1 Month
-13.46%
-13.46%
3 Month
-10.00%
-10.00%
6 Month
-51.09%
-51.09%
1 Year
-10.00%
-10.00%

More News

Read More
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why DBV Technologies Stock Is Soaring Today
Via The Motley Fool
Dow Rises 150 Points; Mission Produce Shares Slide
Via Benzinga
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Dow Surges Over 100 Points; Crude Oil Rises Sharply
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why DBV Technologies Shares Are Trading Higher By 38%; Here Are 26 Stocks Moving Premarket
Via Benzinga
DBV Technologies Shares Jumps As FDA Lifts Partial Hold On Pivotal Trial For Peanut Allergy Patch
Via Benzinga
US Stocks Look To Close Volatile Week On A High — Fed's Preferred Inflation Gauge, New Home Sales Data, Tesla, AMC In Spotlight
Via Benzinga
DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivotal Trial
From DBV Technologies S.A.
Via Globe NewsWire
Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2022
From DBV Technologies S.A.
Via Globe NewsWire
DBV Technologies to Participate in Upcoming Investor Conference
From DBV Technologies S.A.
Via Globe NewsWire
DBV Technologies to Highlight New Clinical Data at ACAAI 2022
From DBV Technologies S.A.
Via Globe NewsWire
DBV Technologies Reports Third Quarter Financial Results and Business Update
From DBV Technologies S.A.
Via Globe NewsWire
DBV Technologies to Report Third Quarter 2022 Financial Results and Provide a Business Update
From DBV Technologies S.A.
Via Globe NewsWire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2022
From DBV Technologies S.A.
Via Globe NewsWire
DBV Technologies Announces Appointment of New Chair of its Audit Committee and Appointment of Daniele Guyot-Caparros to Board of Directors
From DBV Technologies S.A.
Via Globe NewsWire
Algoma Steel Group, Sandstorm Gold And Some Other Big Stocks Moving Lower On Tuesday
Via Benzinga
11 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.